Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.76655634 |
2 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.28107564 |
3 | * negative T cell selection (GO:0043383) | 7.04175472 |
4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.02800921 |
5 | * negative thymic T cell selection (GO:0045060) | 6.72163885 |
6 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.67985411 |
7 | response to interleukin-15 (GO:0070672) | 6.38431742 |
8 | regulation of gamma-delta T cell activation (GO:0046643) | 6.33727361 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.24469543 |
10 | negative regulation of cell killing (GO:0031342) | 6.24469543 |
11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.19783438 |
12 | interferon-gamma production (GO:0032609) | 6.18885411 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.15982314 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.15982314 |
15 | cellular response to interleukin-15 (GO:0071350) | 6.13228266 |
16 | * thymic T cell selection (GO:0045061) | 5.96588997 |
17 | * T cell selection (GO:0045058) | 5.57812962 |
18 | * positive thymic T cell selection (GO:0045059) | 5.48030738 |
19 | T cell costimulation (GO:0031295) | 5.46975116 |
20 | * T cell receptor signaling pathway (GO:0050852) | 5.45391605 |
21 | lymphocyte costimulation (GO:0031294) | 5.42874896 |
22 | * positive T cell selection (GO:0043368) | 5.37618619 |
23 | regulation of T cell tolerance induction (GO:0002664) | 5.33898711 |
24 | regulation of regulatory T cell differentiation (GO:0045589) | 5.23457775 |
25 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.10807787 |
26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03749014 |
27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.94748845 |
28 | tolerance induction (GO:0002507) | 4.93207990 |
29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.91916734 |
30 | positive regulation of isotype switching (GO:0045830) | 4.77524242 |
31 | activated T cell proliferation (GO:0050798) | 4.70009317 |
32 | regulation of isotype switching (GO:0045191) | 4.63035261 |
33 | positive regulation of granulocyte differentiation (GO:0030854) | 4.51610789 |
34 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.43815812 |
35 | positive regulation of tolerance induction (GO:0002645) | 4.42473426 |
36 | positive regulation of interleukin-2 production (GO:0032743) | 4.42256813 |
37 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.35221462 |
38 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.35221462 |
39 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.32899683 |
40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.32899683 |
41 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.26825950 |
42 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.19173148 |
43 | positive regulation of B cell mediated immunity (GO:0002714) | 4.19173148 |
44 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.18407279 |
45 | positive regulation of humoral immune response (GO:0002922) | 4.17249097 |
46 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.14357503 |
47 | positive regulation of DNA recombination (GO:0045911) | 4.09206835 |
48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.07949564 |
49 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.02854461 |
50 | * T cell migration (GO:0072678) | 3.98729611 |
51 | regulation of B cell mediated immunity (GO:0002712) | 3.98261859 |
52 | regulation of immunoglobulin production (GO:0002637) | 3.97849786 |
53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92830754 |
54 | detection of bacterium (GO:0016045) | 3.79706659 |
55 | NIK/NF-kappaB signaling (GO:0038061) | 3.79644126 |
56 | regulation of tolerance induction (GO:0002643) | 3.78474461 |
57 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.75183709 |
58 | positive regulation of immunoglobulin production (GO:0002639) | 3.71336592 |
59 | detection of other organism (GO:0098543) | 3.69753091 |
60 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.69043150 |
61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68528494 |
62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.66219301 |
63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.66133689 |
64 | regulation of response to interferon-gamma (GO:0060330) | 3.63858290 |
65 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.62667179 |
66 | positive regulation by symbiont of host defense response (GO:0052509) | 3.59679428 |
67 | modulation by symbiont of host defense response (GO:0052031) | 3.59679428 |
68 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.59679428 |
69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.59679428 |
70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.59679428 |
71 | modulation by symbiont of host immune response (GO:0052553) | 3.59679428 |
72 | alpha-beta T cell differentiation (GO:0046632) | 3.59429236 |
73 | B cell receptor signaling pathway (GO:0050853) | 3.57086399 |
74 | response to muramyl dipeptide (GO:0032495) | 3.55659943 |
75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.53711453 |
76 | * T cell differentiation (GO:0030217) | 3.50528004 |
77 | alpha-beta T cell activation (GO:0046631) | 3.50094589 |
78 | mast cell activation (GO:0045576) | 3.49600414 |
79 | negative regulation of phagocytosis (GO:0050765) | 3.48615998 |
80 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.48095270 |
81 | * leukocyte aggregation (GO:0070486) | 3.47102785 |
82 | regulation of interleukin-2 production (GO:0032663) | 3.46633422 |
83 | positive regulation of B cell differentiation (GO:0045579) | 3.46005542 |
84 | sequestering of actin monomers (GO:0042989) | 3.44441581 |
85 | T cell homeostasis (GO:0043029) | 3.43864179 |
86 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.42361747 |
87 | Peyers patch development (GO:0048541) | 3.42361747 |
88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.41059933 |
89 | cellular extravasation (GO:0045123) | 3.40693106 |
90 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38854484 |
91 | positive regulation of cell killing (GO:0031343) | 3.37814669 |
92 | negative regulation of interleukin-12 production (GO:0032695) | 3.36278944 |
93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34575614 |
94 | regulation of cell killing (GO:0031341) | 3.34265565 |
95 | regulation of immunoglobulin secretion (GO:0051023) | 3.33969082 |
96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.32685087 |
97 | regulation of granulocyte differentiation (GO:0030852) | 3.31016607 |
98 | type I interferon signaling pathway (GO:0060337) | 3.30474832 |
99 | cellular response to type I interferon (GO:0071357) | 3.30474832 |
100 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.30249841 |
101 | response to type I interferon (GO:0034340) | 3.30195770 |
102 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.29712280 |
103 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.28470557 |
104 | * T cell activation (GO:0042110) | 3.27960834 |
105 | neutrophil activation involved in immune response (GO:0002283) | 3.26215428 |
106 | cellular response to interleukin-4 (GO:0071353) | 3.26111047 |
107 | regulation of interleukin-4 production (GO:0032673) | 3.25220703 |
108 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.24908065 |
109 | positive regulation of interleukin-4 production (GO:0032753) | 3.24764057 |
110 | T-helper cell differentiation (GO:0042093) | 3.24492273 |
111 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.24492273 |
112 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.23787122 |
113 | natural killer cell activation (GO:0030101) | 3.23194431 |
114 | negative regulation of innate immune response (GO:0045824) | 3.22043734 |
115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.21109080 |
116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20109356 |
117 | regulation of defense response to virus by virus (GO:0050690) | 3.16683062 |
118 | * positive regulation of T cell activation (GO:0050870) | 3.16422398 |
119 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.14503309 |
120 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.14136857 |
121 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.12238375 |
122 | natural killer cell differentiation (GO:0001779) | 3.11553625 |
123 | regulation of chronic inflammatory response (GO:0002676) | 3.11302732 |
124 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.08545697 |
125 | regulation of B cell differentiation (GO:0045577) | 3.07028769 |
126 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.06925219 |
127 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.05804226 |
128 | lymphocyte homeostasis (GO:0002260) | 3.05235876 |
129 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03417578 |
130 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.03114897 |
131 | T cell differentiation involved in immune response (GO:0002292) | 3.03114897 |
132 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.03114897 |
133 | T cell lineage commitment (GO:0002360) | 3.02076106 |
134 | leukocyte degranulation (GO:0043299) | 2.97591258 |
135 | signal complex assembly (GO:0007172) | 2.96970573 |
136 | neutrophil activation (GO:0042119) | 2.92139058 |
137 | * regulation of alpha-beta T cell activation (GO:0046634) | 2.89918620 |
138 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.88603951 |
139 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.88603951 |
140 | regulation of T cell mediated immunity (GO:0002709) | 2.87898959 |
141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.87381546 |
142 | respiratory burst (GO:0045730) | 2.85956801 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.60172657 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.95821353 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 3.88564512 |
4 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.55183336 |
5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.51730457 |
6 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.48354571 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.45676404 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.27941251 |
9 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.22671415 |
10 | MYB_26560356_Chip-Seq_TH2_Human | 3.21978026 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.18328685 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.15319772 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 3.00343839 |
14 | MYB_26560356_Chip-Seq_TH1_Human | 2.71769243 |
15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.71487782 |
16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.71085153 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58073284 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49148985 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38393191 |
20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26805416 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22708794 |
22 | MAF_26560356_Chip-Seq_TH2_Human | 2.22666124 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18133360 |
24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.17618729 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09226877 |
26 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.07477622 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95523632 |
28 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.92227330 |
29 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85794222 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82814188 |
31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77093929 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75739158 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68140054 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.66529628 |
35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64873304 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62973182 |
37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61279254 |
38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56963188 |
39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56117991 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54054293 |
41 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52561359 |
42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51581454 |
43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50919039 |
44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48172063 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48003853 |
46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42639916 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40377341 |
48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38490580 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34998470 |
50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34511619 |
51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33006361 |
52 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30994109 |
53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30728184 |
54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29854060 |
55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25947394 |
56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25944813 |
57 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25097752 |
58 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.25011349 |
59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.23277948 |
60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22628284 |
61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18378351 |
62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16051953 |
63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15660952 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15631877 |
65 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.15435763 |
66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12022205 |
67 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11868859 |
68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11470094 |
69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10968985 |
70 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10792213 |
71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10572159 |
72 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08157410 |
73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07043722 |
74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06648010 |
75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06076713 |
76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05624155 |
77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05531450 |
78 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05076152 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03945987 |
80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02839458 |
81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02250321 |
82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01570697 |
83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00140905 |
84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99964162 |
85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99214042 |
86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98649238 |
87 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98309767 |
88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97964436 |
89 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97536012 |
90 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96823692 |
91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96510360 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95615735 |
93 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95603914 |
94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95370641 |
95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92964754 |
96 | P68_20966046_ChIP-Seq_HELA_Human | 0.91269855 |
97 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89763641 |
98 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89740316 |
99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89417351 |
100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.89031925 |
101 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.86912511 |
102 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86747089 |
103 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85824274 |
104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83676338 |
105 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83148640 |
106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81872781 |
107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81709039 |
108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81218488 |
109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81154091 |
110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79711145 |
111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79296577 |
112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78462392 |
113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78412461 |
114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.78151196 |
115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78148443 |
116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78004698 |
117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77787603 |
118 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.77127637 |
119 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.76922851 |
120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76507415 |
121 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.76177149 |
122 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75725525 |
123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.73982333 |
124 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73552772 |
125 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.73451841 |
126 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.72281080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0003763_abnormal_thymus_physiology | 5.74272633 |
2 | MP0005671_abnormal_response_to | 4.87516129 |
3 | MP0000685_abnormal_immune_system | 3.74958261 |
4 | MP0002166_altered_tumor_susceptibility | 3.24066023 |
5 | MP0005387_immune_system_phenotype | 3.15645615 |
6 | MP0001790_abnormal_immune_system | 3.15645615 |
7 | MP0001835_abnormal_antigen_presentation | 3.13503656 |
8 | * MP0001800_abnormal_humoral_immune | 3.13086959 |
9 | MP0009333_abnormal_splenocyte_physiolog | 2.98169838 |
10 | * MP0002398_abnormal_bone_marrow | 2.83484035 |
11 | MP0006082_CNS_inflammation | 2.79555453 |
12 | * MP0005000_abnormal_immune_tolerance | 2.76755921 |
13 | MP0001873_stomach_inflammation | 2.76220885 |
14 | * MP0002723_abnormal_immune_serum | 2.75677589 |
15 | * MP0002420_abnormal_adaptive_immunity | 2.74330942 |
16 | MP0009785_altered_susceptibility_to | 2.74133159 |
17 | * MP0000703_abnormal_thymus_morphology | 2.72220429 |
18 | MP0003300_gastrointestinal_ulcer | 2.71510626 |
19 | * MP0001819_abnormal_immune_cell | 2.70095897 |
20 | MP0002006_tumorigenesis | 2.62248509 |
21 | * MP0002405_respiratory_system_inflammati | 2.61585558 |
22 | MP0003866_abnormal_defecation | 2.52761384 |
23 | MP0005025_abnormal_response_to | 2.46305153 |
24 | * MP0000716_abnormal_immune_system | 2.43919879 |
25 | * MP0002452_abnormal_antigen_presenting | 2.42884402 |
26 | MP0003303_peritoneal_inflammation | 2.38972941 |
27 | * MP0002722_abnormal_immune_system | 2.33569135 |
28 | MP0010155_abnormal_intestine_physiology | 2.27255045 |
29 | MP0002396_abnormal_hematopoietic_system | 2.21939056 |
30 | * MP0000689_abnormal_spleen_morphology | 2.21463388 |
31 | MP0004947_skin_inflammation | 2.12406839 |
32 | * MP0003436_decreased_susceptibility_to | 2.08369976 |
33 | * MP0002429_abnormal_blood_cell | 1.98062245 |
34 | MP0004510_myositis | 1.93148405 |
35 | MP0001853_heart_inflammation | 1.88172271 |
36 | MP0001845_abnormal_inflammatory_respons | 1.69145134 |
37 | MP0004381_abnormal_hair_follicle | 1.62652931 |
38 | * MP0002933_joint_inflammation | 1.62441374 |
39 | MP0002419_abnormal_innate_immunity | 1.59788940 |
40 | MP0002148_abnormal_hypersensitivity_rea | 1.59531833 |
41 | MP0005464_abnormal_platelet_physiology | 1.46466561 |
42 | MP0005310_abnormal_salivary_gland | 1.41288722 |
43 | MP0003172_abnormal_lysosome_physiology | 1.41220479 |
44 | MP0008260_abnormal_autophagy | 1.36956000 |
45 | MP0004808_abnormal_hematopoietic_stem | 1.36767610 |
46 | MP0000858_altered_metastatic_potential | 1.33413861 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.27623592 |
48 | MP0000490_abnormal_crypts_of | 1.23565383 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.20102856 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.17945710 |
51 | MP0002132_abnormal_respiratory_system | 1.17461439 |
52 | MP0008469_abnormal_protein_level | 1.15009711 |
53 | MP0003448_altered_tumor_morphology | 1.11669884 |
54 | MP0002277_abnormal_respiratory_mucosa | 1.11188896 |
55 | MP0002019_abnormal_tumor_incidence | 1.10372221 |
56 | MP0008057_abnormal_DNA_replication | 1.05419873 |
57 | MP0001986_abnormal_taste_sensitivity | 1.05394859 |
58 | MP0003828_pulmonary_edema | 1.05313043 |
59 | MP0008961_abnormal_basal_metabolism | 1.04050991 |
60 | MP0005075_abnormal_melanosome_morpholog | 0.97256511 |
61 | MP0001851_eye_inflammation | 0.94996598 |
62 | MP0003693_abnormal_embryo_hatching | 0.94547525 |
63 | * MP0001533_abnormal_skeleton_physiology | 0.94016097 |
64 | MP0000604_amyloidosis | 0.93204976 |
65 | MP0005023_abnormal_wound_healing | 0.92788584 |
66 | MP0000609_abnormal_liver_physiology | 0.91385987 |
67 | MP0004130_abnormal_muscle_cell | 0.87783165 |
68 | MP0009763_increased_sensitivity_to | 0.83028193 |
69 | MP0003077_abnormal_cell_cycle | 0.82181710 |
70 | MP0004883_abnormal_blood_vessel | 0.82114162 |
71 | MP0002998_abnormal_bone_remodeling | 0.81667804 |
72 | MP0004957_abnormal_blastocyst_morpholog | 0.81253842 |
73 | MP0005397_hematopoietic_system_phenotyp | 0.80465668 |
74 | MP0001545_abnormal_hematopoietic_system | 0.80465668 |
75 | MP0010352_gastrointestinal_tract_polyps | 0.78011330 |
76 | MP0003183_abnormal_peptide_metabolism | 0.77384292 |
77 | MP0009765_abnormal_xenobiotic_induced | 0.75323665 |
78 | MP0002009_preneoplasia | 0.73514266 |
79 | MP0003690_abnormal_glial_cell | 0.70652429 |
80 | MP0000477_abnormal_intestine_morphology | 0.69998087 |
81 | MP0001348_abnormal_lacrimal_gland | 0.68718979 |
82 | MP0005076_abnormal_cell_differentiation | 0.67662783 |
83 | MP0003045_fibrosis | 0.67252759 |
84 | MP0002822_catalepsy | 0.66421946 |
85 | MP0001663_abnormal_digestive_system | 0.65832186 |
86 | MP0001881_abnormal_mammary_gland | 0.63387773 |
87 | MP0000015_abnormal_ear_pigmentation | 0.61524977 |
88 | MP0005451_abnormal_body_composition | 0.59367596 |
89 | * MP0005390_skeleton_phenotype | 0.58765540 |
90 | MP0009764_decreased_sensitivity_to | 0.57842966 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.56651951 |
92 | MP0010094_abnormal_chromosome_stability | 0.54436032 |
93 | MP0004185_abnormal_adipocyte_glucose | 0.54220494 |
94 | MP0005360_urolithiasis | 0.53917212 |
95 | * MP0003795_abnormal_bone_structure | 0.52820929 |
96 | MP0001216_abnormal_epidermal_layer | 0.52730784 |
97 | MP0005058_abnormal_lysosome_morphology | 0.52583434 |
98 | MP0008873_increased_physiological_sensi | 0.50031681 |
99 | MP0000313_abnormal_cell_death | 0.49028115 |
100 | MP0005381_digestive/alimentary_phenotyp | 0.48030991 |
101 | MP0000598_abnormal_liver_morphology | 0.48013879 |
102 | * MP0003724_increased_susceptibility_to | 0.47409449 |
103 | MP0002136_abnormal_kidney_physiology | 0.46264249 |
104 | MP0003111_abnormal_nucleus_morphology | 0.46164098 |
105 | MP0005365_abnormal_bile_salt | 0.45523014 |
106 | MP0008874_decreased_physiological_sensi | 0.45359932 |
107 | MP0005164_abnormal_response_to | 0.45301492 |
108 | MP0009840_abnormal_foam_cell | 0.45150723 |
109 | MP0008007_abnormal_cellular_replicative | 0.44906313 |
110 | MP0003787_abnormal_imprinting | 0.43643049 |
111 | MP0003091_abnormal_cell_migration | 0.43104435 |
112 | MP0000367_abnormal_coat/_hair | 0.42039709 |
113 | MP0001191_abnormal_skin_condition | 0.42033825 |
114 | MP0002254_reproductive_system_inflammat | 0.41057391 |
115 | MP0008058_abnormal_DNA_repair | 0.41052306 |
116 | MP0000350_abnormal_cell_proliferation | 0.40835014 |
117 | MP0005166_decreased_susceptibility_to | 0.39942445 |
118 | MP0009278_abnormal_bone_marrow | 0.39672718 |
119 | MP0008995_early_reproductive_senescence | 0.39425551 |
120 | MP0002693_abnormal_pancreas_physiology | 0.39349787 |
121 | MP0001765_abnormal_ion_homeostasis | 0.38848439 |
122 | MP0000249_abnormal_blood_vessel | 0.38683068 |
123 | MP0009115_abnormal_fat_cell | 0.38079810 |
124 | MP0003279_aneurysm | 0.37611008 |
125 | MP0004264_abnormal_extraembryonic_tissu | 0.36939175 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 8.06588786 |
2 | Abnormality of T cell number (HP:0011839) | 7.77427395 |
3 | Stomatitis (HP:0010280) | 6.12134694 |
4 | Abnormality of T cells (HP:0002843) | 5.93353424 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.43980169 |
6 | Recurrent bronchitis (HP:0002837) | 5.19151575 |
7 | IgG deficiency (HP:0004315) | 5.02578363 |
8 | * Eczematoid dermatitis (HP:0000976) | 4.77331365 |
9 | IgM deficiency (HP:0002850) | 4.74184416 |
10 | Recurrent abscess formation (HP:0002722) | 4.67789932 |
11 | Increased IgM level (HP:0003496) | 4.63026953 |
12 | Recurrent bacterial skin infections (HP:0005406) | 4.60584578 |
13 | Nasal polyposis (HP:0100582) | 4.60505438 |
14 | Myositis (HP:0100614) | 4.27426942 |
15 | B lymphocytopenia (HP:0010976) | 4.27350080 |
16 | Abnormality of B cell number (HP:0010975) | 4.27350080 |
17 | Abnormality of macrophages (HP:0004311) | 4.14681625 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.10945042 |
19 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.10945042 |
20 | * Severe combined immunodeficiency (HP:0004430) | 4.09066473 |
21 | * Combined immunodeficiency (HP:0005387) | 4.07705316 |
22 | Abnormality of T cell physiology (HP:0011840) | 4.02128910 |
23 | Chronic diarrhea (HP:0002028) | 4.00678515 |
24 | Recurrent viral infections (HP:0004429) | 3.97444702 |
25 | Abnormality of eosinophils (HP:0001879) | 3.87829525 |
26 | Optic neuritis (HP:0100653) | 3.87493101 |
27 | Retrobulbar optic neuritis (HP:0100654) | 3.87493101 |
28 | Autoimmune hemolytic anemia (HP:0001890) | 3.86074651 |
29 | Chronic otitis media (HP:0000389) | 3.85852262 |
30 | Joint swelling (HP:0001386) | 3.85487802 |
31 | Abnormality of the nasal mucosa (HP:0000433) | 3.78995172 |
32 | * Recurrent fungal infections (HP:0002841) | 3.73280570 |
33 | Pustule (HP:0200039) | 3.73056356 |
34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.62218609 |
35 | Abnormality of the fingertips (HP:0001211) | 3.57336505 |
36 | Gastrointestinal infarctions (HP:0005244) | 3.54166331 |
37 | Lymphopenia (HP:0001888) | 3.49574099 |
38 | IgA deficiency (HP:0002720) | 3.48004997 |
39 | Thyroiditis (HP:0100646) | 3.47175407 |
40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.41074258 |
41 | Eosinophilia (HP:0001880) | 3.38250564 |
42 | Leukocytosis (HP:0001974) | 3.38208444 |
43 | Hypoplasia of the thymus (HP:0000778) | 3.38015659 |
44 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.37773758 |
45 | Orchitis (HP:0100796) | 3.35918300 |
46 | Papilledema (HP:0001085) | 3.32228979 |
47 | Prolonged bleeding time (HP:0003010) | 3.32083105 |
48 | Hemoptysis (HP:0002105) | 3.27244313 |
49 | Vasculitis (HP:0002633) | 3.11717067 |
50 | Increased density of long bones (HP:0006392) | 3.09994100 |
51 | Pulmonary infiltrates (HP:0002113) | 3.09946263 |
52 | Granulocytopenia (HP:0001913) | 2.99975551 |
53 | Bronchitis (HP:0012387) | 2.99870859 |
54 | Encephalitis (HP:0002383) | 2.97472995 |
55 | Meningitis (HP:0001287) | 2.92723857 |
56 | Lymphoma (HP:0002665) | 2.85993264 |
57 | Hypergammaglobulinemia (HP:0010702) | 2.81727906 |
58 | Keratoconjunctivitis sicca (HP:0001097) | 2.81563166 |
59 | Colitis (HP:0002583) | 2.81231052 |
60 | Arterial thrombosis (HP:0004420) | 2.79537241 |
61 | Gingivitis (HP:0000230) | 2.77328882 |
62 | Hypochromic anemia (HP:0001931) | 2.73926854 |
63 | Thrombocytosis (HP:0001894) | 2.73085779 |
64 | Autoimmune thrombocytopenia (HP:0001973) | 2.72280309 |
65 | Pulmonary embolism (HP:0002204) | 2.69999407 |
66 | Recurrent sinusitis (HP:0011108) | 2.67760527 |
67 | Cellulitis (HP:0100658) | 2.60708081 |
68 | Basal cell carcinoma (HP:0002671) | 2.58816033 |
69 | Chest pain (HP:0100749) | 2.55106247 |
70 | Slow saccadic eye movements (HP:0000514) | 2.54832744 |
71 | Keratoconjunctivitis (HP:0001096) | 2.53017067 |
72 | Gangrene (HP:0100758) | 2.49163440 |
73 | Spontaneous hematomas (HP:0007420) | 2.47534508 |
74 | Urticaria (HP:0001025) | 2.43840507 |
75 | Increased IgE level (HP:0003212) | 2.42339538 |
76 | Obstructive lung disease (HP:0006536) | 2.41317023 |
77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41317023 |
78 | Mediastinal lymphadenopathy (HP:0100721) | 2.38395599 |
79 | Inflammation of the large intestine (HP:0002037) | 2.35955871 |
80 | Gastrointestinal inflammation (HP:0004386) | 2.31491550 |
81 | Ureteral stenosis (HP:0000071) | 2.31225960 |
82 | Abnormality of the prostate (HP:0008775) | 2.30458690 |
83 | Hypochromic microcytic anemia (HP:0004840) | 2.29991459 |
84 | Seborrheic dermatitis (HP:0001051) | 2.28476270 |
85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28085919 |
86 | Recurrent skin infections (HP:0001581) | 2.24337068 |
87 | Sepsis (HP:0100806) | 2.23712272 |
88 | Recurrent otitis media (HP:0000403) | 2.22746970 |
89 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20471412 |
90 | Epistaxis (HP:0000421) | 2.20107623 |
91 | Anorexia (HP:0002039) | 2.17210501 |
92 | Episodic fever (HP:0001954) | 2.17133202 |
93 | * Panhypogammaglobulinemia (HP:0003139) | 2.15689371 |
94 | Osteomyelitis (HP:0002754) | 2.11158903 |
95 | Hepatitis (HP:0012115) | 2.10843539 |
96 | Persistence of primary teeth (HP:0006335) | 2.09440848 |
97 | Cheilitis (HP:0100825) | 2.08035590 |
98 | Amaurosis fugax (HP:0100576) | 2.07629062 |
99 | Acute hepatic failure (HP:0006554) | 2.06815704 |
100 | Abnormal platelet volume (HP:0011876) | 2.06382651 |
101 | Viral hepatitis (HP:0006562) | 2.04040971 |
102 | Gingival bleeding (HP:0000225) | 2.03667193 |
103 | Ureteral obstruction (HP:0006000) | 2.03579061 |
104 | Stomach cancer (HP:0012126) | 2.03249942 |
105 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.01054488 |
106 | Fatigue (HP:0012378) | 1.97317750 |
107 | Agammaglobulinemia (HP:0004432) | 1.97028131 |
108 | Skin ulcer (HP:0200042) | 1.96856564 |
109 | Papilloma (HP:0012740) | 1.93925648 |
110 | Verrucae (HP:0200043) | 1.93925648 |
111 | Chronic sinusitis (HP:0011109) | 1.91894379 |
112 | Polyneuropathy (HP:0001271) | 1.91893984 |
113 | Subacute progressive viral hepatitis (HP:0006572) | 1.89951445 |
114 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89113934 |
115 | Petechiae (HP:0000967) | 1.88211614 |
116 | Arthralgia (HP:0002829) | 1.86677385 |
117 | Teleangiectasia of the skin (HP:0100585) | 1.84241179 |
118 | Emphysema (HP:0002097) | 1.81707969 |
119 | Gastrointestinal stroma tumor (HP:0100723) | 1.81313763 |
120 | Thrombophlebitis (HP:0004418) | 1.81102610 |
121 | Abnormality of the endocardium (HP:0004306) | 1.79990086 |
122 | Frequent falls (HP:0002359) | 1.79669463 |
123 | Abnormality of the pleura (HP:0002103) | 1.78860209 |
124 | Microcytic anemia (HP:0001935) | 1.78659603 |
125 | Glomerulopathy (HP:0100820) | 1.78543064 |
126 | Bronchiectasis (HP:0002110) | 1.77651993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.46547364 |
2 | MAP4K1 | 6.01084936 |
3 | JAK3 | 3.36361939 |
4 | PRPF4B | 3.35052647 |
5 | ITK | 3.07207705 |
6 | FGFR4 | 2.91064983 |
7 | RIPK4 | 2.90716228 |
8 | KDR | 2.82619667 |
9 | * ZAP70 | 2.55321986 |
10 | IKBKE | 2.39670031 |
11 | TESK2 | 2.27960676 |
12 | TAOK3 | 2.19381919 |
13 | TYK2 | 2.09904922 |
14 | STK10 | 2.02840952 |
15 | MAP3K14 | 1.95090904 |
16 | GRK6 | 1.88465674 |
17 | NLK | 1.86955208 |
18 | * LCK | 1.79862199 |
19 | EEF2K | 1.76014291 |
20 | JAK1 | 1.71768428 |
21 | FGFR3 | 1.65437686 |
22 | MAP3K10 | 1.63896594 |
23 | NME2 | 1.60098276 |
24 | ERN1 | 1.59483947 |
25 | TEC | 1.57996120 |
26 | CSK | 1.57921711 |
27 | TBK1 | 1.48189370 |
28 | SYK | 1.39502336 |
29 | HCK | 1.35136807 |
30 | TRIB3 | 1.27421026 |
31 | BTK | 1.26238937 |
32 | IKBKB | 1.23752886 |
33 | CAMKK2 | 1.20990128 |
34 | TAOK1 | 1.19007319 |
35 | CAMKK1 | 1.18999412 |
36 | SMG1 | 1.16359308 |
37 | PRKCQ | 1.14756248 |
38 | PRKCH | 1.11251443 |
39 | BLK | 1.11213315 |
40 | MST4 | 1.11002178 |
41 | CHUK | 1.10924573 |
42 | RPS6KA4 | 1.06867277 |
43 | MAP3K7 | 1.04192400 |
44 | CDK12 | 1.03206696 |
45 | MAP3K11 | 0.93317785 |
46 | TNK2 | 0.90725349 |
47 | JAK2 | 0.90719916 |
48 | TSSK6 | 0.90110300 |
49 | PKN2 | 0.87143213 |
50 | FGR | 0.87086460 |
51 | LRRK2 | 0.87075024 |
52 | PIM1 | 0.84835839 |
53 | MAPK12 | 0.82025041 |
54 | MAP3K1 | 0.80016076 |
55 | MAP2K3 | 0.75875209 |
56 | SIK2 | 0.75784863 |
57 | MAPK7 | 0.75619961 |
58 | PTK6 | 0.73897717 |
59 | MAP2K2 | 0.73451553 |
60 | FGFR1 | 0.70522776 |
61 | CDC42BPA | 0.70130075 |
62 | KIT | 0.70107855 |
63 | PRKD2 | 0.68517491 |
64 | TESK1 | 0.66597802 |
65 | PIM2 | 0.66521004 |
66 | EPHA3 | 0.66410448 |
67 | CLK1 | 0.65548535 |
68 | CDK4 | 0.64034044 |
69 | TYRO3 | 0.63935484 |
70 | MARK3 | 0.62891266 |
71 | MAP3K13 | 0.62789514 |
72 | PASK | 0.62576522 |
73 | ALK | 0.61986322 |
74 | FES | 0.60857285 |
75 | PDGFRB | 0.60129809 |
76 | KSR2 | 0.59545783 |
77 | IRAK4 | 0.58049314 |
78 | SIK3 | 0.56636504 |
79 | EPHB1 | 0.53733648 |
80 | * LYN | 0.53070946 |
81 | SIK1 | 0.51520738 |
82 | MARK2 | 0.50640902 |
83 | YES1 | 0.48848610 |
84 | TGFBR1 | 0.46886851 |
85 | PDK1 | 0.44984480 |
86 | TTN | 0.42965688 |
87 | STK38 | 0.42913522 |
88 | RET | 0.42676283 |
89 | RPS6KC1 | 0.41745871 |
90 | RPS6KL1 | 0.41745871 |
91 | STK11 | 0.40989770 |
92 | TAOK2 | 0.40623164 |
93 | RPS6KA5 | 0.39918610 |
94 | FYN | 0.39886165 |
95 | RAF1 | 0.39826875 |
96 | MELK | 0.39749377 |
97 | FGFR2 | 0.39682231 |
98 | EIF2AK1 | 0.39073918 |
99 | BRD4 | 0.38765276 |
100 | DYRK1B | 0.38115875 |
101 | SRPK1 | 0.38090459 |
102 | PDPK1 | 0.36680139 |
103 | MAP3K12 | 0.36623601 |
104 | BMPR2 | 0.36570961 |
105 | CSF1R | 0.36377790 |
106 | RPS6KA6 | 0.35380590 |
107 | MAP3K8 | 0.35340596 |
108 | IGF1R | 0.34670852 |
109 | MAPK11 | 0.34161377 |
110 | MAP3K3 | 0.33414098 |
111 | * INSR | 0.32682124 |
112 | HIPK2 | 0.32155046 |
113 | SGK3 | 0.31499987 |
114 | CAMK4 | 0.30543702 |
115 | CDK9 | 0.30141179 |
116 | TGFBR2 | 0.29837414 |
117 | NEK2 | 0.29298193 |
118 | IRAK1 | 0.27565540 |
119 | NEK6 | 0.26347219 |
120 | BUB1 | 0.26241632 |
121 | ICK | 0.25822832 |
122 | ROCK2 | 0.24729387 |
123 | UHMK1 | 0.24303215 |
124 | MAP2K6 | 0.23629583 |
125 | CDK6 | 0.22918528 |
126 | MAPKAPK2 | 0.22630575 |
127 | STK4 | 0.22229453 |
128 | RPS6KA1 | 0.21947950 |
129 | MAPK3 | 0.21895780 |
130 | DMPK | 0.20120468 |
131 | CHEK1 | 0.19405269 |
132 | NTRK2 | 0.19378728 |
133 | STK24 | 0.19283504 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 5.52917638 |
2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.22903555 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.82006932 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 3.65271803 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.37684463 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.09445160 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.06324602 |
8 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.94857465 |
9 | Measles_Homo sapiens_hsa05162 | 2.88439832 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.67519604 |
11 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45246001 |
12 | Asthma_Homo sapiens_hsa05310 | 2.06735821 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01521687 |
14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95095879 |
15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.81088566 |
16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77683959 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67152348 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57464224 |
19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47636092 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44553241 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43758188 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43483770 |
23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.37743255 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32537842 |
25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23304347 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22391174 |
27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22237209 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.21239711 |
29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.21004007 |
30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19966437 |
31 | Ribosome_Homo sapiens_hsa03010 | 1.19616448 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.16262824 |
33 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12016457 |
34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10698179 |
35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10375731 |
36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10156787 |
37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07889885 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06533349 |
39 | Spliceosome_Homo sapiens_hsa03040 | 1.04481861 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02855271 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97684811 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97112485 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94737268 |
44 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93757155 |
45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93746020 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92331856 |
47 | Influenza A_Homo sapiens_hsa05164 | 0.92100229 |
48 | Apoptosis_Homo sapiens_hsa04210 | 0.90122224 |
49 | Legionellosis_Homo sapiens_hsa05134 | 0.88847774 |
50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.86616239 |
51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86570251 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86142335 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82159328 |
54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81503068 |
55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80427533 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74774628 |
57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74417249 |
58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.73777882 |
59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72297048 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71895777 |
61 | Proteasome_Homo sapiens_hsa03050 | 0.69733500 |
62 | Malaria_Homo sapiens_hsa05144 | 0.69414051 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.66020759 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64745024 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63747123 |
66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63144679 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62957385 |
68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61915842 |
69 | RNA degradation_Homo sapiens_hsa03018 | 0.61793572 |
70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60662932 |
71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56940642 |
72 | RNA transport_Homo sapiens_hsa03013 | 0.56803849 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56430145 |
74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56357839 |
75 | Salmonella infection_Homo sapiens_hsa05132 | 0.53025309 |
76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52104320 |
77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51497251 |
78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50802149 |
79 | Platelet activation_Homo sapiens_hsa04611 | 0.50623960 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49224064 |
81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48912380 |
82 | Phagosome_Homo sapiens_hsa04145 | 0.48872405 |
83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48745907 |
84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48355373 |
85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48125601 |
86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47904618 |
87 | Pertussis_Homo sapiens_hsa05133 | 0.47684074 |
88 | Tuberculosis_Homo sapiens_hsa05152 | 0.47398254 |
89 | DNA replication_Homo sapiens_hsa03030 | 0.46437108 |
90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45936939 |
91 | Glioma_Homo sapiens_hsa05214 | 0.44756257 |
92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44194636 |
93 | Base excision repair_Homo sapiens_hsa03410 | 0.42958456 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42651280 |
95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41137167 |
96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39966053 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39105604 |
98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38316949 |
99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37652897 |
100 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.37330914 |
101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35544567 |
102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33883787 |
103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32926059 |
104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32848986 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.32525764 |
106 | Mismatch repair_Homo sapiens_hsa03430 | 0.32001006 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.29324111 |
108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28984006 |
109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.27771464 |
110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26784671 |
111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25512005 |
112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23536368 |
113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23306922 |
114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.23293873 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21983642 |
116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21356926 |
117 | RNA polymerase_Homo sapiens_hsa03020 | 0.21156580 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20644281 |
119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.20142851 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.17514913 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17411344 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16392650 |
123 | Lysine degradation_Homo sapiens_hsa00310 | 0.14799383 |
124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13768782 |
125 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.13078371 |
126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12949380 |
127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12613642 |